Publication: Pectin-hydroxyprophylmethylcellulose drug delivery system for colon targeting: Design and in vitro evaluation
| dc.contributor.authors | Turkoglu M., Takka S., Baran H., Sakr A. | |
| dc.date.accessioned | 2022-03-28T14:50:39Z | |
| dc.date.accessioned | 2026-01-10T19:15:58Z | |
| dc.date.available | 2022-03-28T14:50:39Z | |
| dc.date.issued | 1999 | |
| dc.description.abstract | Pectin-Hydroxypropylmethylcellulose (HPMC) matrix tablets were prepared and evaluated of their dissolution/erosion properties to assess their colon targeting possibility based on a gastrointestinal transit time concept. Dosage forms were tested in water and also separately in 0.1 N HCl and pH 6.8 buffer systems. HPMCs of three different molecular weights were incorporated as 25% into a pectin USP matrix in addition to pure pectin tablets. The effect of a pectin-degrading enzyme (Pectinex 3XL) on dissolution rate was also studied. It was found that dissolution/erosion rates were faster in water than in buffer solutions. The t50 values were 3, 3.4, 5.0, and 6.0 h in water and 4.6, 5.3, 9.7, and 11.7 h in a buffer system dependent on the viscosity grade of HPMC. Addition of 25% HPMC improved the mechanical properties of pectin matrix. Pectinex 3XL accelerated the degradation of pectin tablets as well as HPMC content of matrix. Pectin-HPMC system is recommended as protective wall layers to protect and carry protein drugs to the colon for targeting. | |
| dc.identifier.issn | 0031711X | |
| dc.identifier.uri | https://hdl.handle.net/11424/255497 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Pharmazeutische Industrie | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Colon targeting | |
| dc.subject | Dissolution | |
| dc.subject | Drug targeting | |
| dc.subject | E rosion | |
| dc.subject | Hydroxypropylmethylcellulose | |
| dc.subject | Pectin | |
| dc.subject | Pectinase | |
| dc.subject | Tablets | |
| dc.title | Pectin-hydroxyprophylmethylcellulose drug delivery system for colon targeting: Design and in vitro evaluation | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 665 | |
| oaire.citation.issue | 7 | |
| oaire.citation.startPage | 662 | |
| oaire.citation.title | Pharmazeutische Industrie | |
| oaire.citation.volume | 61 |
